semaglutide and sumatriptan Dr Blitz: Medicare Deal for GLP-1 “Just What the Doctor Ordered” Wegovy Semaglutide 0.25mg injection at

In patients with comorbid coronary artery disease, obesity, and diabetes, GLP-1 agonists and SGLT-2 inhibitors should be used as first-line agents, over metformin

In general, a lower dose of Ozempic tends to result in fewer pounds lost, while a higher dose will result in more significant weight loss

- Novo Nordisk

The use of biologic agents that target allergic inflammation has revolutionized the treatment of people who do not have full responses to the standard inhalational therapy mentioned above, yet there are still patients who have uncontrolled disease

Preserving lean mass including skeletal muscle Because GLP1based therapies are associated with ~30% of total weight loss coming from lean body mass 1 loss as weight falls, using a Diabetes Specific Nutritional Formula like Glucerna can help supply high-quality protein and micronutrients to support muscle maintenance (coupled with resistance exercise)